A study from CNIC reveals how risk factors and subclinical atherosclerosis affect heart microcirculation in asymptomatic middle-aged individuals. The research, published in JACC: Cardiovascular Imaging, highlights the importance of assessing the heart vessels’ ability to regulate blood flow and predict...

Two studies carried out at the CNIC provide key information about a newly identified cardiovascular risk factor, clonal hematopoiesis, and its treatment with the ancient medication colchicine

Guiomar Mendieta has been awarded the 2023 William W. Parmley Young Author Achievement Award for a paper published in JACC that is considered to an outstanding contribution in the field of atherosclerosis

The most potent genetic risk factor for Alzheimer disease, APOE4, is associated with an elevated risk of developing subclinical atherosclerosis in middle age, whereas the Alzheimer-protective variant of the same gene, APOE2, protects against subclinical atherosclerosis

Atherosclerosis, previously believed to be an irreversible progressive disease, can be reversed if risk factors are contolled early enough

A new CNIC study shows that low-grade systemic inflammation triggered by subcinical atherosclerosis accelerates epigenetic aging in otherwise healthy young individuals

In Spain, only 16% of professionals in the STEM area are women. On this March 8th we have prepared this action so that young people can know about 4 women from the CNIC who are part of the PESA HEALTH...

Adherence to a workplace cardiovascular health-promotion program improves lifestyle and risk factors in healthy individuals

This new discovery paves the way to new research avenues toward the discovery of interventions to prevent or arrest atherosclerosis

Scientists at the CNIC have led the development of a new three-dimensional ultrasound method that improves the assessment of cardiovascular risk in healthy individuals